NCT01203644View on ClinicalTrials.gov

Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

December 31, 2006

Conditions
Inguinal Hernia
Interventions
DRUG

SKY0402

Single dose of SKY0402 administered locally into the surgical wound.

DRUG

Bupivacaine HCl

Single dose of bupivacaine HCl (100 mg) administered locally into the surgical wound.

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY